Form 4 for LFMD LifeMD, Inc.
Accepted 2021-12-07 00:00:00 ET · period of report 2019-09-30 · accession 0001362118-21-000051 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2021-12-07 | 2021-12-03 | LFMD | Velge Bertrand | Dir | P - Purchase | $3.91 | +110.0K | 891.7K | +14% | +$430.1K |
| DM | 2021-12-07 | 2020-04-15+ | LFMD | Velge Bertrand | Dir | P - Purchase | $0.289 | +391.0K | 511.5K | +325% | +$113.0K |
| D | 2021-12-07 | 2020-08-05 | LFMD | Velge Bertrand | Dir | A - Grant | $0.00 | +173.2K | 684.7K | +34% | $0 |
| DM | 2021-12-07 | 2019-09-30+ | LFMD | Velge Bertrand | Dir | A - Grant | $0.00 | +120.0K | 100.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-03 | P | A | 110,000 | $3.91 | 891,666 | I | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.80 to $4.02, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth. |
| 2 | Common | Common Stock | 2020-09-22 | P | A | 96,923 | $0.65 | 781,666 | D | — | — | (F3) Issued in connection with Exchange Agreement dated September 22, 2020 whereby shares of common stock and warrants were exchanged for outstanding debt. |
| 3 | Common | Common Stock | 2020-08-05 | A | A | 173,234 | $0.00 | 684,743 | D | — | — | (F5) Issued pursuant to anti-dilution provisions contained in the Securities Purchase Agreement dated May 31, 2019. |
| 4 | Common | Common Stock | 2020-04-15 | P | A | 294,118 | $0.17 | 511,509 | D By Aliunde LLC | — | — | |
| 5 | Derivative | Stock Option (Right to Buy) | 2020-03-31 | A | A | 2,500 | $0.00 | 2,500 | D | $1.20 · 2021-03-31 to 2025-03-31 | 2,500 Common Stock | (F4) Issued as director's compensation. |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-03-31 | A | A | 2,500 | $0.00 | 2,500 | D | $11.98 · 2021-03-31 to 2026-03-31 | 2,500 Common Stock | (F4) Issued as director's compensation. |
| 7 | Derivative | Stock Option (Right to Buy) | 2020-12-31 | A | A | 2,500 | $0.00 | 2,500 | D | $7.00 · 2020-12-31 to 2025-12-31 | 2,500 Common Stock | (F4) Issued as director's compensation. |
| 8 | Derivative | Stock Option (Right to Buy) | 2020-09-30 | A | A | 2,500 | $0.00 | 2,500 | D | $7.95 · 2020-09-30 to 2025-09-30 | 2,500 Common Stock | (F4) Issued as director's compensation. |
| 9 | Derivative | Stock Option (Right to Buy) | 2019-09-30 | A | A | 2,500 | $0.00 | 2,500 | D | $1.15 · 2019-09-30 to 2024-09-30 | 2,500 Common Stock | (F4) Issued as director's compensation. |
| 10 | Derivative | Stock Option (Right to Buy) | 2019-12-31 | A | A | 2,500 | $0.00 | 2,500 | D | $1.15 · 2019-12-31 to 2024-12-31 | 2,500 Common Stock | (F4) Issued as director's compensation. |
| 11 | Derivative | Stock Option (Right to Buy) | 2020-06-30 | A | A | 2,500 | $0.00 | 2,500 | D | $11.56 · 2021-06-30 to 2026-06-30 | 2,500 Common Stock | (F4) Issued as director's compensation. |
| 12 | Derivative | Stock Option (Right to Buy) | 2020-06-30 | A | A | 2,500 | $0.00 | 2,500 | D | $1.50 · 2020-06-30 to 2025-06-30 | 2,500 Common Stock | (F4) Issued as director's compensation. |
| 13 | Derivative | Warrants to Purchase Common Stock | 2020-09-22 | A | A | 100,000 | $0.00 | 100,000 | D | $4.65 · 2020-09-22 to 2024-09-22 | 100,000 Common Stock |